# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this w...
Benchmark analyst Bruce Jackson initiates coverage on Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price T...
Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price targe...
The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.